Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling
- PMID: 18198340
- PMCID: PMC2192757
- DOI: 10.1101/gad.1617608
Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling
Abstract
Hypoxia induces rapid and dramatic changes in cellular metabolism, in part through inhibition of target of rapamycin (TOR) kinase complex 1 (TORC1) activity. Genetic studies have shown the tuberous sclerosis tumor suppressors TSC1/2 and the REDD1 protein to be essential for hypoxia regulation of TORC1 activity in Drosophila and in mammalian cells. The molecular mechanism and physiologic significance of this effect of hypoxia remain unknown. Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14-3-3 proteins. Endogenous REDD1 is required for both dissociation of endogenous TSC2/14-3-3 and inhibition of mTORC1 in response to hypoxia. REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1. In vitro, loss of REDD1 signaling promotes proliferation and anchorage-independent growth under hypoxia through mTORC1 dysregulation. In vivo, REDD1 loss elicits tumorigenesis in a mouse model, and down-regulation of REDD1 is observed in a subset of human cancers. Together, these findings define a molecular mechanism of signal integration by TSC1/2 that provides insight into the ability of REDD1 to function in a hypoxia-dependent tumor suppressor pathway.
Figures
Similar articles
-
Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.Mol Cell Biol. 2011 May;31(9):1870-84. doi: 10.1128/MCB.01393-10. Epub 2011 Mar 7. Mol Cell Biol. 2011. PMID: 21383064 Free PMC article.
-
Growth control under stress: mTOR regulation through the REDD1-TSC pathway.Cell Cycle. 2005 Nov;4(11):1500-02. doi: 10.4161/cc.4.11.2139. Epub 2005 Nov 1. Cell Cycle. 2005. PMID: 16258273 Review.
-
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.Genes Dev. 2004 Dec 1;18(23):2893-904. doi: 10.1101/gad.1256804. Epub 2004 Nov 15. Genes Dev. 2004. PMID: 15545625 Free PMC article.
-
Regulation of mTOR and cell growth in response to energy stress by REDD1.Mol Cell Biol. 2005 Jul;25(14):5834-45. doi: 10.1128/MCB.25.14.5834-5845.2005. Mol Cell Biol. 2005. PMID: 15988001 Free PMC article.
-
A complex interplay between Akt, TSC2 and the two mTOR complexes.Biochem Soc Trans. 2009 Feb;37(Pt 1):217-22. doi: 10.1042/BST0370217. Biochem Soc Trans. 2009. PMID: 19143635 Free PMC article. Review.
Cited by
-
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death.Cell Death Discov. 2024 Jan 5;10(1):8. doi: 10.1038/s41420-023-01779-2. Cell Death Discov. 2024. PMID: 38182566 Free PMC article.
-
Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors.Sci Rep. 2023 Nov 8;13(1):19403. doi: 10.1038/s41598-023-46484-3. Sci Rep. 2023. PMID: 37938616 Free PMC article.
-
Regulation of alveolar macrophage death in pulmonary fibrosis: a review.Apoptosis. 2023 Dec;28(11-12):1505-1519. doi: 10.1007/s10495-023-01888-4. Epub 2023 Sep 14. Apoptosis. 2023. PMID: 37707713 Free PMC article. Review.
-
The stress-responsive protein REDD1 and its pathophysiological functions.Exp Mol Med. 2023 Sep;55(9):1933-1944. doi: 10.1038/s12276-023-01056-3. Epub 2023 Sep 1. Exp Mol Med. 2023. PMID: 37653030 Free PMC article. Review.
-
Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease.Int J Mol Sci. 2023 Aug 13;24(16):12736. doi: 10.3390/ijms241612736. Int J Mol Sci. 2023. PMID: 37628917 Free PMC article. Review.
References
-
- Arsham A.M., Howell J.J., Simon M.C. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 2003;278:29655–29660. - PubMed
-
- Blouw B., Song H., Tihan T., Bosze J., Ferrara N., Gerber H.P., Johnson R.S., Bergers G. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 2003;4:133–146. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous